Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction

Sponsor
HaEmek Medical Center, Israel (Other)
Overall Status
Completed
CT.gov ID
NCT00437931
Collaborator
(none)
60
1
12
5

Study Details

Study Description

Brief Summary

Overt hyperthyroidism and hypothyroidism are associated with inverted hemodynamic changes.Regional blood flow disturbances (including intrathyroidal) were also reported in these thyroid disorders. The purpose of this study is to investigate the thyroid vascularity and blood flow by Color Flow Doppler Sonography in patients with subclinical thyroid dysfunction

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Color Flow Doppler Sonography (CFDS) has become in the last years an increasing procedure to assess the thyroid blood flow. Previous studies showed specific changes of thyroid blood flow in hyperthyroidism, Hashimoto's thyroiditis and thyroid nodules when investigated by CFDS. Subclinical hyperthyroidism and hypothyroidism are common laboratory findings, defined by normal thyroid hormones concentrations along with ,respectively,decreased or increase Thyroid stimulating hormone (TSH) level. We purpose to investigate thyroid vascularity by CFDS in patients with subclinical hyperthyroidism or hypothyroidism and compared them with euthyroid patients.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    60 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Study Start Date :
    Feb 1, 2007
    Actual Primary Completion Date :
    Feb 1, 2008
    Actual Study Completion Date :
    Feb 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    A

    patients with subclinical hypothyroidism

    B

    patients with subclinical hyperthyroidism

    C

    patient with normal thyroid function.

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 75 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • patients with subclinical hypothyroidism or hyperthyroidism

      • patients with thyroid nodules and normal thyroid function

      Exclusion Criteria:
      • patients who are taking thyroxine, antithyroid drugs, lithium or amiodarone

      • patients who had thyroid surgery or radioiodine therapy

      • patients with NYHA class 3 or 4 heart failure

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Haemek Medical Center, Department of Radiology Afula Israel 18101

      Sponsors and Collaborators

      • HaEmek Medical Center, Israel

      Investigators

      • Principal Investigator: Avraham Ishay, MD, Haemek Medical Center, Endocrine Institute, Afula, Israel
      • Study Chair: Leonid Chervinsky, Haemek Medical Center, Department of Radiology, Afula , Israel
      • Study Chair: Rafael Luboshitzky, MD, Haemek Medical Center, Endocrine Institute, Afula, Israel

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      avraham ishay, Dr, HaEmek Medical Center, Israel
      ClinicalTrials.gov Identifier:
      NCT00437931
      Other Study ID Numbers:
      • 006-07-EMC
      First Posted:
      Feb 21, 2007
      Last Update Posted:
      Sep 8, 2016
      Last Verified:
      Sep 1, 2016
      Keywords provided by avraham ishay, Dr, HaEmek Medical Center, Israel
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Sep 8, 2016